To study the effects of NFκB and AP-1 upregulated gene expression in ER-positive breast cancer cells, two TAM-resistant ER-positive/ERBB2-positive breast cancer cell lines, MCF7/HER2 and BT474, were evaluated in relation to TAM-sensitive ER-positive/ERBB2-negative MCF7 cells. This evidence concerns the gene JUN and breast carcinoma.